Safety and Efficacy of VDPHL01 in Males and Females With AGA

Exclusion Criteria

• •Subject has uncontrolled blood pressure;
• •Subject has symptoms or history of certain heart or thyroid conditions;
• •Subject has a history of cardiac and/or thyroid diseases;
• •Subject has received an organ transplant;
• •Subject has a history of prescription drug abuse or illicit drug use within 6 months of screening; history of alcohol abuse within 6 months prior to screening;
• •Subject has a current or recent history of dietary or weight changes;
• •Subject has been diagnosed with COVID-19 within 16 weeks of baseline;
• •Subject has used any topical scalp treatments for hair growth within 4 weeks prior to screening;
• •Subject has had any scalp procedures, including surgical, laser, light or energy treatments, micro-needling, etc. within 6 months prior to screening;
• •Subject has had previous radiation of the scalp;
• •Subject has used systemic cimetidine, ketoconazole, diazoxide, or corticosteroids (including intramuscular, intraarticular, and intralesional injections) within 12 weeks prior to screening;
• •Subject has used systemic beta blockers within 12 weeks prior to screening;
• •Subject is currently enrolled in an investigational drug, biologic, or device study or has used an investigational treatment within 30 days prior to screening;
• •Subject has used any other therapy with any medication either topical or oral that might, in the investigator's opinion, interfere with the study.